| Nominee | Forecast | Background |
|---|---|---|
Independent | WATCH Prior 97.5% 70808793100 | Pamela Arway served as CEO of American Express Australia Limited from 2004 to 2005 and has been Independent Chairperson of Iron Mountain's Board since 2022. |
Independent | HEALTHY Prior 98.3% 70808793100 | Barbara J. Desoer served as CEO of Citibank, N.A. from 2014 to 2019 and led the integration of Countrywide at Bank of America. |
Independent | HEALTHY Prior 98.8% 70808793100 | Jason Hollar has served as CEO of Cardinal Health since September 2022 and was previously CFO of Tenneco and Sears Holding Corporation. |
Independent | HEALTHY Prior 99.9% 70808793100 | Gregory J. Moore led Microsoft Health and Life Sciences from 2019 to 2023 and founded Google Cloud Healthcare and Life Sciences from 2016 to 2019. |
Independent | HEALTHY Prior 99.9% 70808793100 | Dennis W. Pullin has served as President and CEO of Virtua Health since 2017 and was previously President of MedStar Harbor Hospital from 2009 to 2017. |
Not independent | HEALTHY Prior 99.9% 70808793100 | Javier J. Rodriguez has served as CEO of DaVita Inc. since June 2019 and has been on the board of Gilead Sciences, Inc. since June 2020. |
Independent | HEALTHY Prior 99.6% 70808793100 | Adam H. Schechter has served as President and CEO of Labcorp since November 2019 and was previously President, Global Human Health at Merck from 2010 to 2018. |
Independent | HEALTHY Prior 99.6% 70808793100 | Wendy L. Schoppert served as Executive Vice President and CFO of Sleep Number Corporation from 2011 to 2014 and currently serves on the Board of Directors of Sun Country Airlines and Fossil Group. |
Independent | WATCH Prior 99.7% 70808793100 | Phyllis R. Yale served as Chair of the Blue Cross Blue Shield of Massachusetts Board from 2014 to 2019 and has been on the board of Bristol Myers Squibb since November 2019. |
| #1 | Election of Directors Filed by the board · Board recommends For Elect nine director nominees each to serve until the 2027 Annual Meeting or until their successors are duly elected and qualified. |
| #2 | Ratification of Appointment of Independent Registered Public Accounting Firm (KPMG LLP Filed by the board · Board recommends For Ratify the Audit Committee’s appointment of KPMG LLP as DaVita’s independent registered public accounting firm for fiscal year 2026. |
| #3 | Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay Filed by the board · Board recommends For An advisory, non-binding vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. Detail ›This proposal asks stockholders to cast an advisory (non-binding) vote approving the Company’s named executive officer (NEO) compensation as disclosed in the Proxy Statement. Management is seeking shareholder approval to confirm that its compensation design — which emphasizes a high proportion of at-risk pay tied to short-term and long-term performance metrics (including Adjusted Operating Income, Free Cash Flow, Adjusted EPS and Relative TSR), and a mix of PSUs, RSUs and SSARs — aligns executives’ incentives with the Company’s strategic objectives and stockholder interests. The Compensation Committee frames the program as pay-for-performance with formulaic STI and PSU metrics, and retains limited discretion only to apply negative adjustments; it also emphasizes share ownership requirements, clawback policies, double-trigger change-of-control provisions and other governance features. The context includes recent operational developments (IKC profitability, international expansion, cybersecurity incident response) and strong stockholder engagement and prior high say-on-pay votes, which management cites to justify continuation of the program. The vote is advisory and non-binding, but the Board and Compensation Committee commit to considering the results when making future compensation decisions. A failure to approve would not automatically change pay arrangements but would likely trigger heightened engagement with major investors and could prompt the Compensation Committee to redesign elements of the program to better reflect stockholder concerns. Given the company’s disclosure of robust performance metrics, multi-year incentives, and safeguards against excessive risk-taking, the Board recommends a FOR vote because it believes approval supports continuity of an executive compensation framework that it views as focused on long-term value creation and alignment with stockholders. The analysis for sophisticated investors should weigh the program’s heavy reliance on equity-based awards (sensitive to stock price movements), the mechanics of PSU adjustments (including permitted pre-established adjustments), and the broader governance practices (independent Compensation Committee, independent chair, recoupment policies) when assessing whether the advisory endorsement appropriately reflects stockholder interests. |
| Holder | % of shares | Position value |
|---|---|---|
| BERKSHIRE HATHAWAY INC | 23.56% | $2.32B |
| BERKSHIRE HATHAWAY INC | 23.32% | $2.30B |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.40% | $335M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.30% | $227M |
| STATE STREET CORP | 2.11% | $208M |
| Invesco Ltd. | 2.06% | $204M |
| BlackRock, Inc. | 2.06% | $203M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.73% | $171M |
| DIMENSIONAL FUND ADVISORS LP | 1.66% | $164M |
| LSV ASSET MANAGEMENT | 1.45% | $143M |
| Quarterly report (10-Q) | View › | |
| Definitive proxy (DEF 14A) | View › | |
| Annual report (10-K) | View › | |
| Quarterly report (10-Q) | View › | |
| Quarterly report (10-Q) | View › | |
| Definitive proxy (DEF 14A) | View › |
About the risk forecast
The risk forecast scores each director on the company’s slate against Boardroom Alpha’s YoY Director-Vote Forecast model — three XGBoost classifiers that estimate the probability the director’s vote support falls below 70%, 80%, and 90% at the upcoming annual meeting, augmented by a five-rule governance escalation layer (overboarding, audit-committee composition, prior dissent, and others).
Bands map to those probability thresholds:
- Crisis — high probability of vote support below 70%. Rare.
- Material — high probability of below 80%. The primary screening threshold.
- Elevated — significant elevated risk of dissent.
- Watch — even a mild withhold is detectable. Informational.
- Healthy — no signal of meaningful dissent.
Prior is the director’s most-recent vote-support percentage at this same board. Direction compares the forecast to that prior vote: ↑ expected better means more support than last year; ↓ expected worse means less.
Forecast applies only to non-contested annual proxies (DEF 14A). Contested situations are tracked separately on the contested-proxy pipeline. The model is retrained nightly; bands shown reflect the most recent run.
« Back to Shareholder Meeting Calendar
Frequently Asked Questions
Last updated: